sirtuin SIRT3 mitochondrial
Selected indexed studies
- 2-APQC, a small-molecule activator of Sirtuin-3 (SIRT3), alleviates myocardial hypertrophy and fibrosis by regulating mitochondrial homeostasis. (Signal Transduct Target Ther, 2024) [PMID:38744811]
- Enhanced SIRT3 expression restores mitochondrial quality control mechanism to reverse osteogenic impairment in type 2 diabetes mellitus. (Bone Res, 2025) [PMID:40025004]
- Mitochondrial Sirtuin 3: New emerging biological function and therapeutic target. (Theranostics, 2020) [PMID:32724473]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- 2-APQC, a small-molecule activator of Sirtuin-3 (SIRT3), alleviates myocardial hypertrophy and fibrosis by regulating mitochondrial homeostasis. (2024) pubmed
- Enhanced SIRT3 expression restores mitochondrial quality control mechanism to reverse osteogenic impairment in type 2 diabetes mellitus. (2025) pubmed
- Mitochondrial Sirtuin 3: New emerging biological function and therapeutic target. (2020) pubmed
- SENP1-Sirt3 Signaling Controls Mitochondrial Protein Acetylation and Metabolism. (2019) pubmed
- SIRT3 promotes antimycobacterial defenses by coordinating mitochondrial and autophagic functions. (2019) pubmed
- SIRT3-Mediated Deacetylation of DRP1(K711) Prevents Mitochondrial Dysfunction in Parkinson's Disease. (2025) pubmed
- SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. (2010) pubmed
- Retuning Mitochondrial Apoptosis/Mitophagy Balance via SIRT3-Energized and Microenvironment-Modulated Hydrogel Microspheres to Impede Osteoarthritis. (2023) pubmed
- Mitochondrial Sirtuin-3 (SIRT3) Prevents Doxorubicin-Induced Dilated Cardiomyopathy by Modulating Protein Acetylation and Oxidative Stress. (2022) pubmed
- Mitochondrial sirtuins, metabolism, and aging. (2022) pubmed